CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 122 enrolled
Drug / intervention
VIO Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05410964
NCT05410964N/ACompleted
CompareCT.gov

Non-Linear Imaging of Skin In Vivo: VIO In Vivo Skin Imaging evaluatiON (VISION)

Enspectra Health·observational·Posted Jun 8, 2022·Updated Jan 30, 2024

In Brief

An observational study evaluating VIO System for Skin Cancer and 4 related conditions. Completed, enrolled 122 participants across 1 site.

Detailed Summary

The overall objective of this study is to investigate the potential for the VIO System to display microscopic skin structure in people of different age, sex, race, and skin health.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Cancer, Skin Condition, Skin Diseases, Skin Lesion, Skin Abnormalities
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Cancer Institute (NCI)

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJun 8, 2022
Enrollment StartMar 28, 2018
Primary CompletionJul 29, 2022
Study CompletionAug 6, 2022
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 4.1 years ago

Interventions

VIO Systemdevice

To investigate the potential for the VIO System to display microscopic skin structure in people of different age, sex, race, and skin health